SCHEMBL20205397

SCHEMBL20205397

CC1(C)c2cc3c(cc2-c2c1cc(-c1cc4ccccc4c4ccccc14)c1oc4ccccc4c21)C(C)(C)c1cc(-c2cc4ccccc4c4ccccc24)c2oc4ccccc4c2c1-3

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 1/20 0.33
▸ HPGD P15428 5/20 0.32
▸ L3MBTL1 Q9Y468 4/20 0.32
▸ HSD17B10 Q99714 3/20 0.32
▸ ALDH1A1 P00352 3/20 0.32
▸ TSHR P16473 2/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ TDP1 Q9NUW8 3/20 0.31
▸ ALK Q9UM73 6/20 0.31
▸ KDM4E B2RXH2 3/20 0.31
▸ MAPT P10636 3/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ ALPI P09923 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ CASP3 P42574 1/20 0.31
▸ RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205442 0.90 PGR (0.36) PGRHPGDL3MBTL1HSD17B10ALDH1A1
SCHEMBL18052802 0.89 TDP1 (0.33) PGRHPGDL3MBTL1HSD17B10ALDH1A1
SCHEMBL20205469 0.88 MAOA (0.36) PGRHPGDL3MBTL1HSD17B10ALDH1A1
SCHEMBL20205635 0.87 PGR (0.34) PGRHPGDL3MBTL1HSD17B10ALK
SCHEMBL20205630 0.86 ALOX5 (0.36) PGRHPGDL3MBTL1HSD17B10ALDH1A1
SCHEMBL20205650 0.85 PGR (0.33) PGRHPGDL3MBTL1HSD17B10ALK
SCHEMBL20205335 0.84 CDC14B (0.40) PGRHPGDL3MBTL1HSD17B10ALDH1A1
SCHEMBL20205465 0.84 KMT2A (0.40) PGRALDH1A1TDP1MEN1GAA
SCHEMBL20205471 0.84 CDC14B (0.40) PGRHPGDALKMAPTMEN1
SCHEMBL20205331 0.84 CDC14B (0.38) PGRHPGDL3MBTL1HSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND PGR 4271/4885HPGD 806/4885L3MBTL1 1006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback